ANI Pharma General Counsel Meredith Cook sells 500 shares for $37,740PUBT·Aug 13 at 03:41 PMANIP-2.55%
Amundi Has $352,000 Holdings in ANI Pharmaceuticals, Inc. $ANIPMarket Beat·Aug 13 at 02:13 AMANIP-2.55%UBS+0.17%
Ori Gutwerg Sells 3,162 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) StockMarket Beat·Aug 11 at 10:07 PMANIP-2.55%UBS+0.17%
ANI Pharma SVP, Generics Ori Gutwerg reports sale of 3,162 common shares worth $243,474PUBT·Aug 11 at 07:58 PMANIP-2.55%
These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Resultsbenzinga_article·Aug 10 at 09:39 AMANIP-2.55%
ANI Pharmaceuticals shares are trading lower despite reporting better-than-expected Q2 results, possibly dragged down by lowered Cortrophin outlook, margin compression, and rising costs.benzinga_article·Aug 7 at 01:26 PMANIP-2.55%
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results | ANIP Stock NewsStockTitan·Aug 6 at 09:50 PMANIP-2.55%
ANIP: Q2 2026 delivered 26% revenue growth, led by Rare Disease and Cortrophin Gel's 43% surgeQuartr·Aug 7 at 06:58 AMANIP-2.55%
ANI Pharmaceuticals (NASDAQ:ANIP) Releases FY 2026 Earnings GuidanceMarket Beat·Aug 7 at 06:26 AMANIP-2.55%
ANI Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 266.04 MEarnings Watch·Aug 7 at 06:02 AMANIP-2.55%
